2015
DOI: 10.1136/archdischild-2015-309156
|View full text |Cite
|
Sign up to set email alerts
|

NICE clinical guideline: bronchiolitis in children: Table 1

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
36
0
1

Year Published

2018
2018
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 50 publications
(40 citation statements)
references
References 10 publications
(7 reference statements)
0
36
0
1
Order By: Relevance
“…(5, 23, 24) These guidelines provide recommendations in terms of prevention, diagnosis, admission criteria, and management of hospitalized children with bronchiolitis with little or no information regarding discharge criteria, which may contribute to the wide variability in length of stay reported among different studies. (2, 4, 8, 10, 25, 26)…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…(5, 23, 24) These guidelines provide recommendations in terms of prevention, diagnosis, admission criteria, and management of hospitalized children with bronchiolitis with little or no information regarding discharge criteria, which may contribute to the wide variability in length of stay reported among different studies. (2, 4, 8, 10, 25, 26)…”
Section: Discussionmentioning
confidence: 99%
“…(1) Different guidelines for the management of children with bronchiolitis have been published. (2–4) Most of these guidelines are focused on admission criteria and the value (or not) of different therapeutic interventions during hospitalization. However, there are no standardized protocols for the discharge of infants and young children with bronchiolitis.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…5 The economic burden among US children requiring hospitalization has been estimated to be $1.73 billion/year. 6 While several diagnostic and therapeutic recommendations for the management of children with bronchiolitis currently exist worldwide, [7][8][9][10][11] these guidelines vary significantly. These variations include several newer therapies for bronchiolitis, such as hypertonic saline, high flow nasal cannula (HFNC), and continuous positive airway pressure (CPAP), for which the evidence supporting their benefit is controversial.…”
mentioning
confidence: 99%
“…An update of this Cochrane review shows a modest reduction of LOS in inpatients, a mild reduction of hospitalisation risk in outpatients and improvement of clinical severity scores when HS is used, although quality of evidence remains low to moderate . The most recent National Institute for Health and Care Excellence guidelines do not recommend treatment with HS at all following the multi‐centre UK Southall and Brent REvisited (SABRE) study showing no difference in time to being declared fit for discharge in comparison with usual care . Additionally, side effects related to the use of nebulised HS, e.g.…”
mentioning
confidence: 99%